Oppenheimer & Co’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-43,920
| Closed | -$509K | – | 1464 |
|
|
2023
Q1 | $509K | Sell |
43,920
-568
| -1% | -$6.58K | 0.01% | 931 |
|
|
2022
Q4 | $364K | Sell |
44,488
-2,608
| -6% | -$21.3K | 0.01% | 1022 |
|
|
2022
Q3 | $273K | Buy |
47,096
+27,096
| +135% | +$157K | 0.01% | 1098 |
|
|
2022
Q2 | $88K | Sell |
20,000
-2,125
| -10% | -$9.35K | ﹤0.01% | 1341 |
|
|
2022
Q1 | $201K | Hold |
22,125
| – | – | ﹤0.01% | 1354 |
|
|
2021
Q4 | $452K | Buy |
+22,125
| New | +$452K | 0.01% | 1082 |
|
|
2021
Q3 | – | Sell |
-13,171
| Closed | -$461K | – | 1555 |
|
|
2021
Q2 | $461K | Buy |
13,171
+1,103
| +9% | +$38.6K | 0.01% | 1070 |
|
|
2021
Q1 | $402K | Buy |
+12,068
| New | +$402K | 0.01% | 1055 |
|
|
2020
Q4 | – | Sell |
-29,361
| Closed | -$290K | – | 1387 |
|
|
2020
Q3 | $290K | Buy |
+29,361
| New | +$290K | 0.01% | 996 |
|